CFGS

Concourse Financial Group Securities Portfolio holdings

AUM $1.77B
1-Year Return 17.35%
This Quarter Return
+7.57%
1 Year Return
+17.35%
3 Year Return
+18.06%
5 Year Return
+62.93%
10 Year Return
AUM
$1.23B
AUM Growth
+$180M
Cap. Flow
+$107M
Cap. Flow %
8.67%
Top 10 Hldgs %
19.25%
Holding
12,249
New
364
Increased
702
Reduced
711
Closed
88

Sector Composition

1 Technology 6.08%
2 Financials 5.32%
3 Healthcare 4.99%
4 Industrials 3.46%
5 Consumer Discretionary 3.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
DJUL icon
10351
FT Vest US Equity Deep Buffer ETF July
DJUL
$405M
0
DK icon
10352
Delek US
DK
$1.68B
0
DKS icon
10353
Dick's Sporting Goods
DKS
$19.9B
0
DLNG icon
10354
Dynagas LNG Partners
DLNG
$141M
0
DLHC icon
10355
DLH Holdings
DLHC
$79.1M
0
DLO icon
10356
dLocal
DLO
$4.03B
0
DLPN icon
10357
Dolphin Entertainment
DLPN
$14M
0
DLS icon
10358
WisdomTree International SmallCap Dividend Fund
DLS
$1.05B
-375
Closed -$19K
DLTH icon
10359
Duluth Holdings
DLTH
$133M
0
DLX icon
10360
Deluxe
DLX
$881M
0
DLY
10361
DoubleLine Yield Opportunities Fund
DLY
$754M
0
DMA
10362
Destra Multi-Alternative Fund
DMA
$78.8M
0
DMAC icon
10363
DiaMedica Therapeutics
DMAC
$366M
0
DMAT icon
10364
Global X Disruptive Materials ETF
DMAT
$5.86M
0
DMCY icon
10365
Democracy International Fund
DMCY
$11M
0
DMF
10366
DELISTED
BNY Mellon Municipal Income
DMF
0
DMRC icon
10367
Digimarc
DMRC
$204M
0
DMXF icon
10368
iShares ESG Advanced MSCI EAFE ETF
DMXF
$839M
0
DMYY icon
10369
dMY Squared
DMYY
$58.6M
0
DMLP icon
10370
Dorchester Minerals
DMLP
$1.2B
0
DMYY.U icon
10371
dMY Squared Technology Group, Inc. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
DMYY.U
$88.7M
0
DMYY.WS icon
10372
dMY Squared Technology Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
DMYY.WS
0
DNA icon
10373
Ginkgo Bioworks
DNA
$593M
0
DNB
10374
DELISTED
Dun & Bradstreet
DNB
0
DNLI icon
10375
Denali Therapeutics
DNLI
$2.07B
0